The Latest Breaking News from Oracle

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

Oracle shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 65 to 81.

Value-oriented investors have done better than growth managers overall at investing this year. A top value fund manager explains his stock picks.

Even as U.S. lawmakers target TikTok, the social media app is morphing into a global giant, taking on Google, Facebook, Snap and others.

As interest rate increases are expected to slow, the pressure on technology businesses might reduce in the upcoming months. Hence, fundamentally strong tech stocks Oracle (ORCL), Gartner (IT), Canon(CAJ), Celestica(CLS), and AstroNova (ALOT) could be great investments to capitalize on the industry’s solid long-term growth prospects. Continue reading….

The Fed is likely to slow its pace of rate hikes over the coming months as inflation shows signs of cooling. Moreover, experts believe the stock market could see a significant rally at the year-end. Hence, fundamentally strong stocks Rimini Street (RMNI), GEE Group (JOB), and Ultralife Corporation (ULBI) might…

The persistent recession fears with the possibility of the Fed maintaining its policy stance until the 2% inflation target is reached have kept the market volatile. Amid the uncertain market conditions, fundamentally strong stocks Oracle (ORCL), CNA Financial (CNA), and Weis Markets (WMK) make worthy additions to your portfolio this…

Oracle sees its Relative Strength Rating enter the 80-plus level.

Despite the recessionary concerns, software spending is expected to remain robust. Moreover, investor sentiment toward software stocks has improved over the past month. Therefore, we think Wall Street favorites Microsoft (MSFT) and Oracle (ORCL) are ideal buys now. Keep reading….